There was progressive BCL1 upregulation in SCC between Stage IV tumors (> 3.89 ± 0.65-fold) and Stage III tumors (2.91 ± 0.58-fold; p = 0.003), as stratified by tumor stage during subgroup analyses. Here, CCND1 is linked to neoplasm.